SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 12th, 2015 • Inpellis, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of August 17, 2015, between Alterix Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
INTELLECTUAL PROPERTY PURCHASE AGREEMENTIntellectual Property Purchase Agreement • November 12th, 2015 • Inpellis, Inc. • Pharmaceutical preparations • Massachusetts
THIS INTELLECTUAL PROPERTY PURCHASE AGREEMENT (the “Agreement”) is entered into as of October 24, 2015 (the “Effective Date”) by and between BioChemics, Inc., a Delaware corporation having an address at 300 Rosewood Drive, Suite 103, Danvers MA 01923 (“BioChemics”) and Inpellis, Inc., a Delaware corporation having an address at 30 Washington Avenue, Suite F, Haddonfield, NJ 08033 (“Inpellis”).
Amendment to Common Stock Purchase WarrantCommon Stock Purchase Warrant • November 12th, 2015 • Inpellis, Inc. • Pharmaceutical preparations • Massachusetts
Amendment to Common Stock Purchase Warrant between Logic International Consulting Group, LLC as (“Holder”) and Alterix, Inc., a Delaware Corporation (“Company”), dated this 10th day of June, 2015.
Alterix Inc. EMPLOYMENT AGREEMENTEmployment Agreement • November 12th, 2015 • Inpellis, Inc. • Pharmaceutical preparations • Massachusetts
THIS EMPLOYMENT AGREEMENT (the “Agreement”), by and between Alterix Inc., a Delaware corporation (“Alterix”), and David R. Staskin, M.D. (the “Executive”) is effective as of September 1, 2015 (the “Effective Date”). Alterix and the Executive are sometimes referred to herein individually as a “Party” and collectively as the “Parties.” In consideration of the the mutual covenants and agreements contained herein and other good and valuable consideration, the receipt and sufficiency of which the Parties hereby acknowledge, the Parties, intending to be legally bound, agree as follows:
Alterix Inc. PROPRIETARY INFORMATION, ASSIGNMENT OF DEVELOPMENTS AND NON- COMPETITION AGREEMENTAnd Non-Competition Agreement • November 12th, 2015 • Inpellis, Inc. • Pharmaceutical preparations • Massachusetts
THIS PROPRIETARY INFORMATION, ASSIGNMENT OF DEVELOPMENTS AND NON-COMPETITION AGREEMENT (“Agreement”), by and between Alterix Inc., a Delaware corporation (“Alterix”), and Patrick Mooney, M.D. (the “Employee”), is effective as of June 11, 2015 (the “Effective Date”).
Alterix Inc. EMPLOYMENT AGREEMENTEmployment Agreement • November 12th, 2015 • Inpellis, Inc. • Pharmaceutical preparations • Pennsylvania
THIS EMPLOYMENT AGREEMENT (the “Agreement”), by and between Alterix Inc., a Delaware corporation (“Alterix”), and Patrick Mooney, M.D. (the “Executive”) is effective as of June 11, 2015 (the “Effective Date”). Alterix and the Executive are sometimes referred to herein individually as a “Party” and collectively as the “Parties.” In consideration of the mutual covenants and agreements contained herein and other good and valuable consideration, the receipt and sufficiency of which the Parties hereby acknowledge, the Parties, intending to be legally bound, agree as follows:
LEASE STREAMWOOD ASSOCIATES/HADDONFIELD, LLC T/A 30 WASHINGTON AVENUE (“LANDLORD”) AND ALTERIX, INC. (“TENANT”)Lease Agreement • November 12th, 2015 • Inpellis, Inc. • Pharmaceutical preparations • New Jersey
This Lease Agreement, made this day of September 2015, by and between STREAMWOOD ASSOCIATES/HADDONFIELD, LLC T/A 30 WASHINGTON AVENUE (C/O The Streamwood Company, 30 Washington Avenue Suite A-1, Haddonfield, New Jersey 08033) hereinafter called the “Landlord” and ALTERIX, INC. presently doing business at 625 Clinton Avenue, Haddonfield, NJ 08033 hereinafter called the “Tenant”.
JOINT OWNERSHIP AGREEMENTJoint Ownership Agreement • November 12th, 2015 • Inpellis, Inc. • Pharmaceutical preparations • Massachusetts
This Joint Ownership Agreement (this “Agreement”) is effective as of October 24, 2015 (the “Effective Date”) by and between BioChemics, Inc., a Delaware corporation having an address at 300 Rosewood Drive, Suite 103, Danvers MA 01923 (“BioChemics”) and Inpellis, Inc., a Delaware corporation having an address at 30 Washington Avenue, Suite F, Haddonfield, NJ 08033 (“Inpellis”). BioChemics and Inpellis are each herein a “Party” and collectively, the “Parties.”
